These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2436533)

  • 21. Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders.
    Malone KM; Waternaux C; Haas GL; Cooper TB; Li S; Mann JJ
    Am J Psychiatry; 2003 Apr; 160(4):773-9. PubMed ID: 12668368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin, suicide and schizophrenia.
    Roy A
    Can J Psychiatry; 1993 Jun; 38(5):369. PubMed ID: 7688651
    [No Abstract]   [Full Text] [Related]  

  • 23. CSF concentrations of neurotensin in schizophrenia: an investigation of clinical and biochemical correlates.
    Breslin NA; Suddath RL; Bissette G; Nemeroff CB; Lowrimore P; Weinberger DR
    Schizophr Res; 1994 Apr; 12(1):35-41. PubMed ID: 7517175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes in the CSF levels of monoamine metabolites in 102 chronic schizophrenic patients following probenecid before and after neuroleptic medication].
    Chen YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Oct; 17(5):273-7. PubMed ID: 6085683
    [No Abstract]   [Full Text] [Related]  

  • 25. The relationship between clinical and biochemical changes following neuroleptic treatment in schizophrenia.
    Cooper SJ; Leahey W; Liddle J; King DJ
    Schizophr Res; 1990; 3(4):261-7. PubMed ID: 1703780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder.
    Sher L; Carballo JJ; Grunebaum MF; Burke AK; Zalsman G; Huang YY; Mann JJ; Oquendo MA
    Bipolar Disord; 2006 Oct; 8(5 Pt 2):543-50. PubMed ID: 17042827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The serotonin hypothesis of (auto)aggression. Critical appraisal of the evidence.
    Van Praag HM; Plutchik R; Conte H
    Ann N Y Acad Sci; 1986; 487():150-67. PubMed ID: 2436530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patients.
    Ninan PT; van Kammen DP; Scheinin M; Linnoila M; Bunney WE; Goodwin FK
    Am J Psychiatry; 1984 Apr; 141(4):566-9. PubMed ID: 6199986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concentrations of cerebrospinal fluid monoamine metabolites in suicides.
    Lester D
    Psychol Rep; 1991 Feb; 68(1):146. PubMed ID: 1709746
    [No Abstract]   [Full Text] [Related]  

  • 31. Serotonin, suicide, and aggression: clinical studies.
    Golden RN; Gilmore JH; Corrigan MH; Ekstrom RD; Knight BT; Garbutt JC
    J Clin Psychiatry; 1991 Dec; 52 Suppl():61-9. PubMed ID: 1721619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CSF 5-hydroxyindoleacetic acid levels and suicide attempts in schizophrenia.
    Lemus CZ; Lieberman JA; Johns CA; Pollack S; Bookstein P; Cooper TB
    Biol Psychiatry; 1990 Apr; 27(8):926-9. PubMed ID: 1691927
    [No Abstract]   [Full Text] [Related]  

  • 33. Biochemical correlates of suicidal behavior in arsonists.
    Lester D
    Psychol Rep; 1989 Feb; 64(1):258. PubMed ID: 2467320
    [No Abstract]   [Full Text] [Related]  

  • 34. Concentrations of monoamine metabolites and chlorpromazine in cerebrospinal fluid for prediction of therapeutic response in psychotic patients treated with neuroleptic drugs.
    Sedvall G
    Prog Biochem Pharmacol; 1980; 16():133-40. PubMed ID: 6160594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CSF monoamine metabolites in depression and schizophrenia.
    Berger PA; Faull KF; Kilkowski J; Anderson PJ; Kraemer H; Davis KL; Barchas JD
    Am J Psychiatry; 1980 Feb; 137(2):174-80. PubMed ID: 7352572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurotransmitter metabolites in medicated epileptic patients.
    Markianos M; Kalfakis N
    Funct Neurol; 1991; 6(4):367-70. PubMed ID: 1725777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoamines, glucose metabolism, suicidal and aggressive behaviors.
    Roy A; Virkkunen M; Guthrie S; Poland R; Linnoila M
    Psychopharmacol Bull; 1986; 22(3):661-5. PubMed ID: 2432627
    [No Abstract]   [Full Text] [Related]  

  • 38. Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism.
    Sher L; Oquendo MA; Li S; Huang YY; Grunebaum MF; Burke AK; Malone KM; Mann JJ
    Neuropsychopharmacology; 2003 Sep; 28(9):1712-9. PubMed ID: 12825091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical markers for suicidal behavior.
    Banki CM
    Am J Psychiatry; 1985 Jan; 142(1):147-8. PubMed ID: 2578258
    [No Abstract]   [Full Text] [Related]  

  • 40. [Biological aspects of suicide].
    Linkowski P; Mendlewicz J
    Acta Psychiatr Belg; 1983; 83(1):7-12. PubMed ID: 6193681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.